246 related articles for article (PubMed ID: 7669564)
1. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Zeng ZS; Guillem JG
Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
[TBL] [Abstract][Full Text] [Related]
2. [Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer].
Ogata Y; Ookita A; Kakegawa T
Nihon Rinsho; 1995 Jul; 53(7):1811-5. PubMed ID: 7630024
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
5. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.
Zeng ZS; Guillem JG
Br J Cancer; 1996 Oct; 74(8):1161-7. PubMed ID: 8883399
[TBL] [Abstract][Full Text] [Related]
6. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
[TBL] [Abstract][Full Text] [Related]
7. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
8. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
9. [Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer].
Koumura H; Sugiyama Y; Kunieda K; Saji S
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():324-31. PubMed ID: 9263524
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
[TBL] [Abstract][Full Text] [Related]
11. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
[TBL] [Abstract][Full Text] [Related]
12. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
13. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
14. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium.
Tyagi SC; Kumar SG; Banks J; Fortson W
J Mol Cell Cardiol; 1995 Oct; 27(10):2177-89. PubMed ID: 8576934
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Ogata Y; Miura K; Ohkita A; Nagase H; Shirouzu K
Kurume Med J; 2001; 48(3):211-8. PubMed ID: 11680936
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
Das SK; Yano S; Wang J; Edwards DR; Nagase H; Dey SK
Dev Genet; 1997; 21(1):44-54. PubMed ID: 9291579
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Yamada T; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Inagaki D; Yamamoto N; Sato T; Fujii S; Numata K; Kunisaki C; Shiozawa M; Morinaga S; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Anticancer Res; 2010 Jul; 30(7):2693-9. PubMed ID: 20683000
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.
Ring P; Johansson K; Höyhtyä M; Rubin K; Lindmark G
Br J Cancer; 1997; 76(6):805-11. PubMed ID: 9310250
[TBL] [Abstract][Full Text] [Related]
20. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
